From: Survival and prognostic factors for adrenocortical carcinoma: a single institution experience
Variable | p | HR | 95 % CI |
---|---|---|---|
Gender (male vs. female) | 0.918 | 1.05 | 0.43–2.58 |
Age (years) (50+ vs. <50) | 0.593 | 1.31 | 0.49–3.54 |
Stage of disease (III–IV vs. I-II) | 0.879 | 1.15 | 0.20–6.71 |
Tumour weight (g) (300+ vs. <300) | 0.665 | 1.35 | 0.34–5.36 |
Lymphatic metastasis (present vs. absent) | 0.001 | 7.37 | 2.31–23.48 |
Distant metastases (present vs. absent) | 0.491 | 1.82 | 0.33–10.09 |
Local infiltration (present vs. absent) | 0.306 | 1.64 | 0.64–4.23 |
Surgical approach (extraperitoneal vs. transperitoneal) | 0.381 | 0.55 | 0.15–2.09 |
Mitotane (used vs. not used) | 0.001 | 0.11 | 0.05–0.27 |